The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Inactivation of the inhA -Encoded Fatty Acid Synthase II (FASII) Enoyl-Acyl Carrier Protein Reductase Induces Accumulation of the FASI End Products and Cell Lysis of Mycobacterium smegmatis
Open accessAbstract
The mechanism of action of isoniazid (INH), a first-line antituberculosis drug, is complex, as mutations in at least five different genes ( katG , inhA , ahpC , kasA , and ndh ) have been found to correlate with isoniazid resistance. Despite this complexity, a preponderance of evidence implicates inhA , which codes for an enoyl-acyl carrier protein reductase of the fatty acid synthase II (FASII), as the primary target of INH. However, INH treatment of Mycobacterium tuberculosis causes the accumulation of hexacosanoic acid (C 26:0 ), a result unexpected for the blocking of an enoyl-reductase. To test whether inactivation of InhA is identical to INH treatment of mycobacteria, we isolated a temperature-sensitive mutation in the inhA gene of Mycobacterium smegmatis that rendered InhA inactive at 42°C. Thermal inactivation of InhA in M. smegmatis resulted in the inhibition of mycolic acid biosynthesis, a decrease in hexadecanoic acid (C 16:0 ) and a concomitant increase of tetracosanoic acid (C 24:0 ) in a manner equivalent to that seen in INH-treated cells. Similarly, INH treatment of Mycobacterium bovis BCG caused an inhibition of mycolic acid biosynthesis, a decrease in C 16:0 , and a concomitant accumulation of C 26:0 . Moreover, the InhA-inactivated cells, like INH-treated cells, underwent a drastic morphological change, leading to cell lysis. These data show that InhA inactivation, alone, is sufficient to induce the accumulation of saturated fatty acids, cell wall alterations, and cell lysis and are consistent with InhA being a primary target of INH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corey, E. J., & Suggs, J. W. (1975) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)75204-x · Cited by 1,777
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 9×
“smegmatis cells and INH-R to inhibition of cell extracts (1).”
BackgroundMethodInfluentialSelf-citationThe catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Self-citationGlickman, M. S., Cox, J. S., & Jacobs, W. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80250-6 · Cited by 655
Self-citationWilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Self-citationInhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Self-citationHeath, R. J., & Rock, C. O. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26538 · Cited by 368
Cohn, D. L., Bustreo, F., & Raviglione, M. C. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s121 · Cited by 340
Telenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
Heym, B., Honoré, N., Schurra, C., Cole, S. T., Heym, B., Truffot-Pernot, C., Grosset, J. H., Banerjee, A., Jacobs, W. R., & van Embden, J. D. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91338-2 · Cited by 263
Self-citationKremer, L., Douglas, J. D., Baulard, A. R., Morehouse, C., Guy, M. R., Alland, D., Dover, L. G., Lakey, J. H., Jacobs, W. R., Brennan, P. J., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000569200 · Cited by 256
Self-citationInhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.103-110.2000 · Cited by 218
Self-citationStudies on the Mechanism of Action of Isoniazid and Ethionamide in the Chemotherapy of Tuberculosis
Johnsson, K., King, D. S., & Schultz, P. G. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00122a038 · Cited by 215
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
Control Mechanisms for Fatty Acid Synthesis in Mycobacterium Smegmatis
Bloch, K. E. (1977) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470122907.ch1 · Cited by 195
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
BERNSTEIN, J., Lott, W. A., Steinberg, B. A., & Yale, H. L. (1952) · PubMed · doi:10.1164/art.1952.65.4.357 · Cited by 160
The Chemical Approach to the Control of Tuberculosis
FOX, H. H. (1952) · Science · doi:10.1126/science.116.3006.129 · Cited by 159
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Self-citationBasso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Self-citationHeinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Mdluli, K. E., Sherman, D. R., Hickey, M. J., Kreiswirth, B. N., Morris, S. L., Stover, C. K., & Barry, C. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.5.1085 · Cited by 112
Mycobacterium phlei Fatty Acid Synthetase—A Bacterial Multienzyme Complex
Brindley, D. N., Matsumura, S., & Bloch, K. E. (1969) · Nature · doi:10.1038/224666a0 · Cited by 109
Exponential-Phase Glycogen Recycling Is Essential for Growth of Mycobacterium smegmatis
Belanger, A. E., & Hatfull, G. F. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.21.6670-6678.1999 · Cited by 103
Chemotherapy of Experimental Tuberculosis.
Perlman, H., BROWN, H., & Raiziss, G. W. (1941) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 86
Rapid quantitation of free fatty acids in human plasma by high-performance liquid chromatography
Mehta, A., Oeser, A. M., & Carlson, M. G. (1998) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00403-4 · Cited by 83
Sköld, O. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.1.49 · Cited by 77
Sequences of the envM gene and of two mutated alleles in Escherichia coli
Bergler, H., Högenauer, G., & Turnowsky, F. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-10-2093 · Cited by 62
Zabinski, R. F., & Blanchard, J. S. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9639731 · Cited by 59
Ristow, M., Möhlig, M., Rifai, M., Schatz, H., Feldmann, K., & Pfeiffer, A. F. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91351-3 · Cited by 36
Klann, A. G., Belanger, A. E., Mello, A. A., Lee, J. Y., & Hatfull, G. F. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.1.65-72.1998 · Cited by 32
Cited by
Pathway to Synthesis and Processing of Mycolic Acids in Mycobacterium tuberculosis
Takayama, K., Wang, C., & Besra, G. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.81-101.2005 · Cited by 660
Mycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
Virulence factors of the Mycobacterium tuberculosis complex
Forrellad, M. A., Klepp, L. I., Gioffré, A., Sabio y García, J., Morbidoni, H. R., Santangelo, M. D. L. P., Cataldi, A. A., & Bigi, F. (2013) · Virulence · doi:10.4161/viru.22329 · Cited by 622
Self-citationBacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery
Campbell, J. W., & Cronan, J. E. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.305 · Cited by 479
Lambert, P. A. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.7.x · Cited by 450
Metadata
- Authors
- Vilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R.
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2000-07-15
- Volume
- 182
- Issue
- 14
- Pages
- 4059-4067
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- OpenAlex
- W2079288441
- Cited by
- 283
- References
- 39
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.